Female Reproductive System Carcinosarcoma

Female Reproductive System Carcinosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

59 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 18
Recruiting: 10
Ph III recruiting: 4
Growth YoY: —
Industry share: 6%
Top sponsor: Mayo Clinic
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (12)

clinicaltrialsPublishedShowing 51–59 of 59 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00114218	Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer	completed	Phase 2	28	Gynecologic Oncology GroupNETWORK	1	Jan 8, 2019	clinicaltrials
NCT00659360	AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma	completed	Phase 2	17	National Cancer Institute (NCI)NIH	2	Jun 29, 2018	clinicaltrials